PAVmed Inc. Financial Ratios
PAVM|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
117.2%
Profit Margin
1328.6%
Net Income / Revenue
Asset Turnover
0.08
Revenue / Total Assets
Equity Multiplier
1.14
Total Assets / Equity
Composite: 117.1% (reported: 117.2%)
Profitability
Liquidity
Current Ratio
0.17
Quick Ratio
0.17
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.08
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
+211.2%
+250.7pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.